48 results
Presentation of the webinar session on "Leveraging CHWs to vaccinate: A review of the global landscape & lessons from Malawi"
Le programme de mise en œuvre de la vaccination antipaludique en Afrique
Depuis 2019, le vaccin est administré dans 3 pays par le biais de programmes nationaux de vaccination des enfants dans le...
The RTS,S/AS01 malaria vaccine. Significantly reduces malaria and life-threatening severe malaria. Since 2019, delivered in childhood vaccination in 3 country-led pilots.
During this fourth session, we hear directly from Malawi and Sierra Leone on their experiences of developing their One Plan One Budget for their COVID-19 vaccination programme. The counties share...
Los sistemas de gestión de datos son fundamentales para proporcionar visibilidad a los datos logísticos de extremo a extremo, pero sólo si "hablan" entre sí. Durante esta sesión, exploraremos...
Les systèmes de gestion des données sont essentiels pour assurer la visibilité des données logistiques de bout en bout, mais seulement s'ils se "parlent" entre eux. Au cours de cette session,...
Data management systems are key for providing logistic data end to end visibility but only if they “talk” to each other. During this session, we will explore how the Government of Malawi is using...
This presentation introduces Logistimo eLMIS solution and a case study from Malawi.
Current live, oral rotavirus vaccines (LORVs) are reducing severe diarrhea in all settings, but they are not as effective in places with the highest burden. Alternative approaches in advanced...
This presentation introduces Logistimo eLMIS solution and a case study from Malawi.
Objective: To provide guidance during the immunization session and ensure prevention of transmission of Corona virus-19 among the population.
An example from Malawi of a diskette which indicates eligibility and windows for catch up vaccination
In 2015, the World Health Organization (WHO) updated the global methodology for assessing and reducing missed opportunities for vaccination (MOV), when eligible children have contact with the health...
Immunization is at the very core of health programs around the world yet its performance is commonly measured by just a single number, namely coverage with a third dose of a vaccine that protects...
This document provides a summary of MCSP/JSI’s experience in the adaptation of the regional Reaching Every District (RED) guideline to country-specific contexts in order to inform other countries...
A reactive campaign using two doses of Shanchol Oral Cholera Vaccine (OCV) was implemented in 2016 in the Lake Chilwa Region (Malawi) targeting fish dependent communities. Three strategies for the...
Home-based record (HBR) for Malawi circa 2011 (female)
Background: Pregnancy increases the risk of harmful effects from cholera for both mothers and their fetuses. A killed oral cholera vaccine, Shanchol (Shantha Biotechnics, Hydrabad, India), can...
BACKGROUND: Empirical evidence regarding the relationship between childhood immunization and individual- and community-level factors in low-income countries has received little attention. We compared...
Despite its promise, however, the digital health landscape today is highly fragmented. The result is a myriad of digital health projects and applications that rarely reach scale and if they were to...
Improving water and sanitation is the preferred choice for cholera control in the long-term. Nevertheless, vaccination is an available too l that has been shown to be a cost‒effective option for...
Growing interest in integration of logistics management information system (LMIS) and health management information system (HMIS) data to improve supply chain performance and service delivery led...
Cholera is transmitted through the fecal-oral route, and humans are the natural host. It is caused by the ingestion of O1 and less commonly O139 serogroups of the Vibrio cholerae bacterium and...
Background
Significant progress has been made to increase access to vaccines in Africa since the 1974 launch of the Expanded Programme on Immunization (EPI). Successes include the introduction of...
Background
Malawi introduced pneumococcal conjugate vaccine (PCV13) and monovalent rotavirus vaccine (RV1) in 2011 and 2012 respectively, and is planning the introduction of a second-dose measles...
A UNICEF review of the challenges to scaling up integrated community case management (iCCM) found that drug shortages were a common bottleneck. In many settings, little thought has gone into the...
Despite some improvement in provision of safe drinking water, proper sanitation and hygiene promotion, cholera still remains a major public health problem in Malawi with outbreaks occurring almost...
This evaluation assesses the extent to which the Advanced Market Commitment (AMC) pilot has achieved its stated objectives and the overarching goal to “reduce morbidity and mortality from...
Vaccination coverage surveys - Publication
abstract: OBJECTIVE: To assess factors related to recorded vaccine
uptake, which may confound the evaluation of vaccine impact.
METHODS: Analysis of...
Understanding post-launch demand for new vaccines can help countries maximize the benefits of immunization programmes. In particular, low- and middle-income countries (LMICs) should ensure adequate...
In seven southern African countries (Botswana, Lesotho, Malawi, Namibia, South Africa, Swaziland and Zimbabwe), following implementation of a measles mortality reduction strategy starting in 1996,...
Acute bacterial meningitis (ABM) is a major cause of illness and death in children in sub-Saharan Africa. Neisseria meningitidis is the most common cause of ABM in the meningitis belt (sub-Saharan...
The Malawi Ministry of Health (MOH) and its immunisation partners conducted a training needs assessment in May 2013 to assess the current status of immunisation training programmemes in health...
The 11th International Rotavirus Symposium brought together over 650
people from 56 countries in New Delhi, India, from 3-5 September, 2014 to examine new surveillance data and studies demonstrating...
Over the past several years, the development of new vaccines, along with global efforts to make them more available and affordable, has resulted in the introduction of lifesaving vaccines in...
Measles was successfully eradicated in the Pan-American Health Region in 2002. However, maintenance of elimination in parts of Africa, Europe, the USA, and other regions is proving difficult, despite...
PROBLEM: Traditional random sampling at community level requires a list of every individual household that can be randomly selected in the study community. The longitudinal demographic surveillance...
This report highlights the achievements made in expanding access to vaccines in Africa and discusses some of the remaining challenges to achieving universal access to vaccines. The timing of this...
While a number of new vaccines have been rolled out across the developing world (with more vaccines in the pipeline), cold chain systems are struggling to efficiently support national immunization...
BACKGROUND:
Rotavirus vaccines have been introduced in many low-income African countries including Malawi in 2012. Despite early evidence of vaccine impact, determining persistence of protection...
Malawi: Redcross in partnership with Katikati using 2-way SMS communication to address rumours, gather insight and support communities
This project brief describes cStock technology used in Malawi that allows for tracking of stock information in districts through text messaging.
Community Health Workers (CHWs) play a critical role bridging the gap between local communities and public health authorities, providing communities with trusted health information and services and...
Technical Brief describing how Community Health Workers (CHWs) administer routine immunization in Malawi
Background: Global chronic health worker shortages and stagnating routine immunization rates require
new strategies to increase vaccination coverage and equity. As trained, trusted members of their...
This Gavi blog describes how CHWs in Malawi are bein deployed to administer COVID-19 vaccines nationally